Src family kinase inhibitor

This page covers all Src family kinase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Src family kinases (SFK).

Targets

Src family kinases (SFK)

Phase 2 pipeline (1)

• AZD0530 Difumarate · Amsterdam UMC, location VUmc · Oncology
  AZD0530 is a Src family kinase inhibitor that blocks intracellular signaling pathways involved in cell proliferation and survival.

Patent intelligence

• src family kinase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates